超声造影在乳腺良恶性肿瘤鉴别诊断中的价值  

Significance of Contrast-enhanced Ultrasonography in Differential Diagnosis of Benign and Malignant Breast Tumors

作　　者：许小云[1] 杜联芳[1] 李凡[1] 邢晋放[1] 仇生龙[2] 王建丰[2] 

机构地区：[1]上海交通大学附属第一人民医院超声科,上海市200080 [2]上海交通大学附属第一人民医院普外科,上海市200080

出　　处：《中国超声医学杂志》2008年第12期1076-1078,共3页Chinese Journal of Ultrasound in Medicine

基　　金：上海市卫生局资助(No.044010)

摘　　要：目的初步探讨超声造影在乳腺良恶性肿瘤鉴别诊断中的价值。方法用声诺维SonoVue造影剂对40例42个乳腺肿块进行超声造影检查,记录并分析造影灌注过程。结果恶性组不均匀增强占84.2%(16/19),良性组不均匀性增强占19.0%(4/21),恶性组高增强占68.4%(13/19),良性组高增强占9.5%(2/21),恶性组以慢退为主(14/19),良性组以快退为主(17/21),恶性组不均匀增强明显大于良性组,恶性组高增强明显大于良性组,两组之间的差异具有显著性意义(P<0.05)。结论超声造影为乳腺良恶性肿瘤的鉴别诊断提供了更加准确的信息,有助于良恶性的鉴别。Objective To explore the value of contrast-enhanced ultrasonography in the differential diagnosis between benign and malignant breast tumors. Methods Fourty-two mammary masses in 40 cases were examined on contrast-enhanced ultrasonography with contrast agent SonoVue and the perfusion record was analyzed. Results Inhomogeneous enhancement was in 84.2 % （16/19 masses） in the malignant group and was 19.0 % （4/ 21） in the benign group; hyper-enhaneement was in 68.4 % （13/19） in the malignant group and was 9.5G （2/ 21） in the benign group;＂ slow out＂ in the most malignant group （14/19）, and ＂ fast out＂ in the most benign group （17/21）. The hyper and inhomogeneous enhancement of the malignant group was higher than that of the benign group. Conclusions Contrast-enhanced ultrasonography may provide exact information for the differential diagnosis of benign and malignant breast tumors and be helpful for the differentiation.

关 键 词：超声检查 造影剂 乳腺肿瘤 

分 类 号：R737.9[医药卫生—肿瘤]